Comparison of different needle diameters and flow rates on bone marrow mononuclear stem cell viability: an ex vivo experimental study

Cytotherapy
M TolO Ilhan

Abstract

Considerable information is available regarding the experimental and clinical applications of bone marrow derived stem cells (BMDSC) for regenerative medicine. Optimized stem cell delivery systems might help to maintain better stem cell viability. We have investigated whether needle diameters and flow rates through the needles cause any difference in terms of BMDSC viability.

References

Apr 28, 2001·The Journal of Thoracic and Cardiovascular Surgery·C RajnochA Carpentier
Nov 15, 2002·International Journal of Hematology·Donald Orlic
Apr 29, 2006·Artificial Organs·A Ruchan AkarUmit Ozyurda

❮ Previous
Next ❯

Citations

Dec 17, 2009·Tissue Engineering. Part C, Methods·Peter A WalkerCharles S Cox
Apr 17, 2010·AJNR. American Journal of Neuroradiology·R El KhouryS I Savitz
Nov 16, 2013·Therapeutic Delivery·Jason J LamannaNicholas M Boulis
Aug 12, 2014·Stem Cell Research & Therapy·Elaine R GarvicanJayesh Dudhia
Mar 7, 2012·Langmuir : the ACS Journal of Surfaces and Colloids·Congqi YanDarrin J Pochan
Jan 31, 2016·Stem Cells Translational Medicine·Mahetab H AmerKevin M Shakesheff
Mar 23, 2017·Veterinary Surgery : VS·Hayley M LangLisa A Fortier
Aug 16, 2017·Drug Delivery and Translational Research·Giulia LeoniMichaela Sharpe
Jan 20, 2021·ACS Biomaterials Science & Engineering·Yasaman AlinejadSophie Lerouge
May 13, 2019·ACS Biomaterials Science & Engineering·James D TangKyle J Lampe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.